AIDS 2020: Virtual
The 23rd International AIDS Conference (AIDS 2020) took place from 6 to 10 July 2020. We were an official scientific media partner for the conference. The conference was held virtually due to coronavirus.
-
6-10 July 2020
-
Virtual/Online
Injectable PrEP offers superior efficacy to oral PrEP in clinical trial
Brazilian man in long-term HIV remission – without a stem cell transplant
Has someone been cured of HIV with a cheap, simple drug regimen?
Opportunistic infections remain common in people taking HIV treatment in Latin America
Recycling tenofovir better than switch to second-line zidovudine
Huge improvements in HIV testing for gay and bisexual men in New South Wales, but some groups left behind
MSM living in African countries that criminalise gay sex are at a much higher risk of getting HIV
Harm reduction for people who inject drugs in Ukraine and Tanzania associated with improved HIV prevention outcomes
Switch to dolutegravir raises the risk of potentially harmful weight gain, four-country African study finds
Islatravir plus doravirine maintains viral suppression for a year
Truvada lawsuit ads are prompting some young people with a high risk of HIV not to start or discontinue PrEP
London study shows people with HIV not at greater risk of severe COVID-19 illness
At least 28,000 women in the United States have started PrEP
Rapid weight gain after switching to TAF, regardless of other HIV drugs taken
People with HIV gain weight faster than HIV-negative people
PrEP prevents an estimated three-quarters of HIV infections in people at risk in large African study